
US drug price overhaul could hit India’s generics industry, warn experts
US President Donald Trump’s recent executive order, aimed at reducing prescription drug prices for Americans, is expected to have significant implications for the global pharmaceutical market, particularly for India’s generics industry. The order seeks to …